Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	758
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	30
Issue number	7
DOIs	https://doi.org/10.1200/JCO.2011.39.7257
Publication status	Published - Mar 1 2012

ASJC Scopus subject areas

@article{b56e967a6e0a47e2a2e0650f8ff37e53,

title = "Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer",

author = "{De Giorgi}, Ugo and Dino Amadori",

year = "2012",

month = mar,

day = "1",

doi = "10.1200/JCO.2011.39.7257",

language = "English",

volume = "30",

pages = "758",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "7",

}

TY - JOUR

T1 - Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer

AU - De Giorgi, Ugo

AU - Amadori, Dino

PY - 2012/3/1

Y1 - 2012/3/1

UR - http://www.scopus.com/inward/record.url?scp=84857531638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857531638&partnerID=8YFLogxK

U2 - 10.1200/JCO.2011.39.7257

DO - 10.1200/JCO.2011.39.7257

M3 - Article

C2 - 22203774

AN - SCOPUS:84857531638

VL - 30

SP - 758

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 7

ER -